ArticleFrontiers in endocrinology2025
Logistic regression analysis of pregnancy outcome and EFI score of infertile patients with ovarian endometriosis cyst after staged oral administration of traditional Chinese medicine.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Multidimensional Perspective Review of Traditional Chinese Medicine in Treating Ovarian Aging.International journal of women's health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ovarian endometriosis cysts are associated with infertility, and recent research increasingly focuses on improving pregnancy outcomes. Traditional Chinese medicine (TCM) has long been used for gynecological issues, yet the impact of staged TCM administration on pregnancy outcomes and Endometriosis Fertility Index (EFI) scores in infertile patients remains underexplored. Objective: This study aims to evaluate the effects of staged TCM administration on pregnancy outcomes and EFI scores in patients with ovarian endometriosis cysts. Method: A retrospective analysis of 150 infertile patients treated with staged TCM administration was conducted. Patients received Formula I before ovulation and Formula II post-ovulation, with the cohort split into pregnancy (n=91) and non-pregnancy groups (n=49). All patients underwent laparoscopic surgery prior to TCM treatment. Logistic regression and ROC analysis were used to assess pregnancy predictors. Results: Significant differences in age, infertility type, infertility duration, r-AFS stage, cyst diameter, and EFI score (P<0.05) were found. Age, secondary infertility, infertility duration (≥3 years), advanced r-AFS stage, cyst diameter (≥3cm), and EFI score (<7) were key risk factors. The EFI score's AUC for predicting pregnancy was 0.731 (95%CI, 0.617-0.844), with 72.58% sensitivity and 75.83% specificity. No significant difference in follow-up duration was observed between the groups. Conclusion: Age, secondary infertility, infertility duration (≥ 3 years), r-AFS stage (stages III and IV), cyst diameter (≥ 3cm), and EFI score (< 7) were identified as risk factors for infertility in patients with ovarian endometriosis following a two-phase staged oral administration of traditional Chinese medicine. Among these factors, the EFI score can serve as a crucial evaluation index for postoperative pregnancy, assessing the likelihood of pregnancy and predicting patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.